Cargando…

The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes

The ratio of ApoB/apolipoprotein A1 (ApoA1) has been found to be associated with type 2 diabetes, and it was proposed as a new biomarker for type 2 diabetes predictions. Previous studies have assumed that the association between apoB/apoA1 and type 2 diabetes was linear. However, the linearity assum...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Yong, Xu, Yang, Lu, Leihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228702/
https://www.ncbi.nlm.nih.gov/pubmed/28072742
http://dx.doi.org/10.1097/MD.0000000000005834
_version_ 1782493992081948672
author Mao, Yong
Xu, Yang
Lu, Leihong
author_facet Mao, Yong
Xu, Yang
Lu, Leihong
author_sort Mao, Yong
collection PubMed
description The ratio of ApoB/apolipoprotein A1 (ApoA1) has been found to be associated with type 2 diabetes, and it was proposed as a new biomarker for type 2 diabetes predictions. Previous studies have assumed that the association between apoB/apoA1 and type 2 diabetes was linear. However, the linearity assumption has rarely been examined. In the present study, we aimed to examine whether this association showed a linear trend in a nationally representative population. Participants aged 18 years and over (n = 8220) were selected from the China Health Nutrition Survey (CHNS). We used restricted cubic spline to model the association between ApoB/ApoA1 ratio and type 2 diabetes using logistic regression models. Additionally, we categorized the ApoB/ApoA1 ratio according to quartiles to compare with previous results. Age, gender, education, smoking status, high sensitivity C-reactive protein (hsCRP), lipid, body mass index (BMI), and hypertension were controlled as potential confounders. We found that the association between apoB/apoA1 ratio and type 2 diabetes may be nonlinear after adjusting for multiple potential confounders. Compared with the lowest quartile of apoB/apoA1 ratio, participants in the fourth quartile had a higher odds of type 2 diabetes [odds ratio (OR) = 1.35, 95% confidence interval (CI) = 1.01–1.81]. Our results suggest that, higher apoB/apoA1 ratio was associated with higher prevalence of type 2 diabetes. However, the association may be nonlinear.
format Online
Article
Text
id pubmed-5228702
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52287022017-01-25 The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes Mao, Yong Xu, Yang Lu, Leihong Medicine (Baltimore) 4300 The ratio of ApoB/apolipoprotein A1 (ApoA1) has been found to be associated with type 2 diabetes, and it was proposed as a new biomarker for type 2 diabetes predictions. Previous studies have assumed that the association between apoB/apoA1 and type 2 diabetes was linear. However, the linearity assumption has rarely been examined. In the present study, we aimed to examine whether this association showed a linear trend in a nationally representative population. Participants aged 18 years and over (n = 8220) were selected from the China Health Nutrition Survey (CHNS). We used restricted cubic spline to model the association between ApoB/ApoA1 ratio and type 2 diabetes using logistic regression models. Additionally, we categorized the ApoB/ApoA1 ratio according to quartiles to compare with previous results. Age, gender, education, smoking status, high sensitivity C-reactive protein (hsCRP), lipid, body mass index (BMI), and hypertension were controlled as potential confounders. We found that the association between apoB/apoA1 ratio and type 2 diabetes may be nonlinear after adjusting for multiple potential confounders. Compared with the lowest quartile of apoB/apoA1 ratio, participants in the fourth quartile had a higher odds of type 2 diabetes [odds ratio (OR) = 1.35, 95% confidence interval (CI) = 1.01–1.81]. Our results suggest that, higher apoB/apoA1 ratio was associated with higher prevalence of type 2 diabetes. However, the association may be nonlinear. Wolters Kluwer Health 2017-01-10 /pmc/articles/PMC5228702/ /pubmed/28072742 http://dx.doi.org/10.1097/MD.0000000000005834 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 4300
Mao, Yong
Xu, Yang
Lu, Leihong
The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes
title The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes
title_full The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes
title_fullStr The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes
title_full_unstemmed The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes
title_short The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes
title_sort nonlinear association between apolipoprotein b to apolipoprotein a1 ratio and type 2 diabetes
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228702/
https://www.ncbi.nlm.nih.gov/pubmed/28072742
http://dx.doi.org/10.1097/MD.0000000000005834
work_keys_str_mv AT maoyong thenonlinearassociationbetweenapolipoproteinbtoapolipoproteina1ratioandtype2diabetes
AT xuyang thenonlinearassociationbetweenapolipoproteinbtoapolipoproteina1ratioandtype2diabetes
AT luleihong thenonlinearassociationbetweenapolipoproteinbtoapolipoproteina1ratioandtype2diabetes
AT maoyong nonlinearassociationbetweenapolipoproteinbtoapolipoproteina1ratioandtype2diabetes
AT xuyang nonlinearassociationbetweenapolipoproteinbtoapolipoproteina1ratioandtype2diabetes
AT luleihong nonlinearassociationbetweenapolipoproteinbtoapolipoproteina1ratioandtype2diabetes